Lemaitre Vascular (LMAT) EV to CFO (2010 - 2026)

Lemaitre Vascular (LMAT) has reported EV to CFO for 17 consecutive years, with 113.87 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO rose 48.05% year-over-year to 113.87 in Q2 2026; TTM through Jun 2026 was 21.91, a 17.51% decrease from a year earlier, with the FY2025 full-year figure at 18.31, down 54.56% from the prior year.
• EV to CFO was 113.87 for Q2 2026 at Lemaitre Vascular, down from 140.93 in the prior quarter.
• Over five years, EV to CFO peaked at 464.85 in Q1 2023 and troughed at 57.09 in Q3 2025.
• A 5-year average of 155.24 and a median of 128.09 in 2024 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO soared 130.7% in 2023 and tumbled 58.6% in 2025, its largest moves.
• Over 5 years, EV to CFO stood at 229.15 in 2022, then sank by 52.78% to 108.21 in 2023, then rose by 8.23% to 117.11 in 2024, then sank by 45.14% to 64.25 in 2025, then soared by 77.24% to 113.87 in 2026.
• The last three EV to CFO figures came in at 113.87 (Q2 2026), 140.93 (Q1 2026), and 64.25 (Q4 2025), per Business Quant data.